All Categories
History
Price (excluding tax)
Response Rate
100.0%
Response Time
88.9hours
Nucleofector™ kits and corresponding optimization protocols are available on a variety of Nucleofector™ platforms for optimal gene transfer into human umbilical vein endothelial cells. The kit of choice for transfecting human umbilical vein endothelial cells in the 4D-Nucleofector™, 96-well Shuttle™ and 384-well Nucleofector™ systems is the P5 Primary Cell Kit. Use in conjunction with cell-specific protocols. The Nucleofector™II/2b device uses a human umbilical vein endothelial cell-specific kit. ■Advantages ・Gene transfer efficiency: up to 90% ・Survival rate: up to 74% ・High expression level of marker protein ・More than 60 papers on human umbilical vein endothelial cells Nucleofection™ have been published ■Applications ・Confirmed with Clonetics™ human umbilical vein endothelial cells ・Ideal for siRNA screening in drug research ・Gene transfer in an adherent state is possible using the 4D Nucleofector™ Y kit
You can search for other models from each index. The displayed value is the value of the currently selected part number.
See all 4 models in listPart Number
Nucleofector™ Kit for Human Umbilical Vein Endothelial Cells (HUVEC)Handling Company
Lonza Co., Ltd.| Image | Price (excluding tax) |
|---|---|
| Available upon quote |
Reviews shown here are reviews of companies.
Response Rate
100.0%
Response Time
88.9hrs
